Open original FDA record ↗Recall record
- FDA identifier
- Z-1489-2026
- Company in FDA record
- Olympus Corporation of the Americas
- FDA classification date
- Mar 3, 2026
- First observed by MedTech Watch
- Nov 16, 2026
- Latest observed content change
- Nov 16, 2026
- Recall classification
- Class II
Reason stated in the source
Potential for rubber fragment detachment during use.
Source facts
- Action
- Olympus notified consignees on about 01/29/2026 via letter titled URGENT: FIELD SAFETY NOTICE. Consignees were instructed to carefully read the content of the notification, ensure all personnel are completely knowledgeable and thoroughly trained on the content of this notification, and that they may continue using the devices as per the notification and instructions for use. Olympus is highlighting the importance of strictly adhering to the Inspection of the Biopsy Valve and Inserting and Withdrawing the Endo-therapy accessories sections in the IFU related to the detachment of fragment from the slit part of rubber. Consignees were requested to acknowledge receipt of the notification via their portal and if product has been further distributed to notify those consignees.
- Initiated
- 2026-01-29
- Root cause
- Under Investigation by firm
- Distribution
- US Nationwide distribution.
- Recall number
- Z-1489-2026
- Recall status
- Open, Classified
- CDRH record ID
- 218000
- FDA classified
- 2026-03-03
- Recall event number
- 98240